基本信息
views: 93
Career Trajectory
Bio
Dr. Yu’s research interests include drug metabolism, pharmacokinetics, pharmacodynamics, noncoding RNAs, anticancer pharmacology and experimental therapeutics. The ultimate goal of his research is to translate noncoding RNAs to new therapies. Current efforts in his laboratory are directed to the investigation of (a) the mechanistic actions of microRNAs in the regulation of cellular processes including drug/xenobiotic/nutrient metabolism and disposition as well as tumor progression and metastasis, (b) novel RNA bioengineering technologies, and (c) recombinant RNAs for basic research and drug development.
Research Interests
Papers共 252 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ASPET 2024 Annual Meeting Abstract - Drug Metabolism and Disposition (DMD) (2024)
RNA (New York, N.Y.)no. 6 (2024): 680-694
ACS SYNTHETIC BIOLOGYno. 6 (2024): 1906-1915
Zhangyi Luo,Yixian Huang,Neelu Batra,Yuang Chen,Haozhe Huang, Yifei Wang,Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang,Jingjing Sun,Qiming Jane Wang,
Nature communicationsno. 1 (2024): 255-255
ASPET 2024 Annual Meeting Abstract - Cellular and Molecular Pharmacology (2024)
Cancer Researchno. 11_Supplement (2023): B023-B023
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2023)
The Journal of pharmacology and experimental therapeuticsno. 1 (2023): 133-154
Current drug metabolismno. 3 (2023): 175-189
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn